Sodium oxybate increases prolactin secretion in narcolepsy patients and healthy controls

European Journal of Endocrinology

Volumn 164, Issue 3, 2011, Pages 363-370

  Donjacour, Claire E H M ^a   Aziz, N Ahmad ^a   Frölich, Marijke ^a   Roelfsema, Ferdinand ^a   Overeem, Sebastiaan ^b,c   Lammers, Gert Jan ^a   Pijl, Hanno ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

OXYBATE SODIUM; PROLACTIN; CENTRAL DEPRESSANT AGENT; OREXIN;

ADULT; ARTICLE; BLOOD SAMPLING; BODY FAT; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; EVENING DOSAGE; HUMAN; INTERVENTION STUDY; MALE; NARCOLEPSY; PRIORITY JOURNAL; PROLACTIN RELEASE; WAIST HIP RATIO; ANIMAL; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; SLEEP; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDY; DRUG EFFICACY; ENTROPY; GENDER; PULSATILE FLOW; SIGNAL TRANSDUCTION; SLEEP PATTERN; SLOW WAVE SLEEP;

ADJUVANTS, ANESTHESIA; ADULT; ANIMALS; HUMANS; MALE; NARCOLEPSY; PROLACTIN; SLEEP; SODIUM OXYBATE;

EID: 79951965205     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0913     Document Type: Article

References (41)

1. Overeem S, Mignot E, van Dijk JG & Lammers GJ. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. Journal of Clinical Neurophysiology 2001 2 78-105. (doi:10.1097/00004691-200103000-00002)
2. Kok SW, Roelfsema F, Overeem S, Lammers GJ, Frolich M, Meinders AE & Pijl H. Altered setting of the pituitary-thyroid ensemble in hypocretin-deficient narcoleptic men. American Journal of Physiology. Endocrinology and Metabolism 2005 5 892-899.
3. Nishino S, Ripley B, Overeem S, Lammers GJ & Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000 9197 39-40. (doi:10.1016/S0140-6736(99)05582-8)
4. Taylor MM & Samson WK. The other side of the orexins: endocrine and metabolic actions. American Journal of Physiology. Endocrinology and Metabolism 2003 1 13-17.
5. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, Nevsimalova S, Aldrich M, Reynolds D, Albin R, Li R, Hungs M, Pedrazzoli M, Padigaru M, Kucherlapati M, Fan J, Maki R, Lammers GJ, Bouras C, Kucherlapati R, Nishino S & Mignot E. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nature Medicine 2000 9 991-997. (doi:10.1038/79690)
6. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M & Siegel JM. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000 3 469-474. (doi:10.1016/S0896-6273(00)00058-1)
7. Lecea de L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM & Sutcliffe JG. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. PNAS 1998 1 322-327. (doi:10.1073/pnas.95.1.322)
8. Peyron C, Tighe DK, van den Pol AN, de LL, Heller HC, Sutcliffe JG & Kilduff TS. Neurons containing hypocretin (orexin) project to multiple neuronal systems. Journal of Neuroscience 1998 23 9996-10015. (Pubitemid 28543775)
9. Hagan JJ, Leslie RA, Patel S, Evans ML, Wattam TA, Holmes S, Benham CD, Taylor SG, Routledge C, Hemmati P, Munton RP, Ashmeade TE, Shah AS, Hatcher JP, Hatcher PD, Jones DN, Smith MI, Piper DC, Hunter AJ, Porter RA & Upton N. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. PNAS 1999 19 10911-10916. (doi:10.1073/pnas.96.19.10911)
10. Samson WK, Taylor MM & Ferguson AV. Non-sleep effects of hypocretin/orexin. Sleep Medicine Reviews 2005 4 243-252. (doi:10.1016/j.smrv. 2004.07.006)
11. Russell SH, Kim MS, Small CJ, Abbott CR, Morgan DG, Taheri S, Murphy KG, Todd JF, Ghatei MA & Bloom SR. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin. Journal of Neuroendocrinology 2000 12 1213-1218. (doi:10.1046/j.1365-2826.2000.00582.x)
12. Freeman ME, Kanyicska B, Lerant A & Nagy G. Prolactin: structure, function, and regulation of secretion. Physiological Reviews 2000 4 1523-1631.
13. Ben-Jonathan N, Hugo ER, Brandebourg TD & LaPensee CR. Focus on prolactin as a metabolic hormone. Trends in Endocrinology and Metabolism 2006 3 110-116. (doi:10.1016/j.tem.2006.02.005)
14. van den Pol AN. Excitatory neuromodulator reduces dopamine release, enhancing prolactin secretion. Neuron 2010 2 147-149. (doi:10.1016/j.neuron. 2010.01.013)
15. Fitzgerald P & Dinan TG. Prolactin and dopamine: what is the connection? A review article Journal of Psychopharmacology 2008 2 (Suppl) 12-19. (doi:10.1177/0269216307087148)
16. Aldrich MS, Hollingsworth Z & Penney JB. Autoradiographic studies of post-mortem human narcoleptic brain. Clinical Neurophysiology 1993 1 35-45. (doi:10.1016/S0987-7053(05)80281-3)
17. Chabas D, Foulon C, Gonzalez J, Nasr M, Lyon-Caen O, Willer JC, Derenne JP & Arnulf I. Eating disorder and metabolism in narcoleptic patients. Sleep 2007 10 1267-1273. (Pubitemid 47548277)
18. Higuchi T, Takahashi Y, Takahashi K, Niimi Y & Miyasita A. Twenty-four-hour secretory patterns of growth hormone, prolactin, and cortisol in narcolepsy. Journal of Clinical Endocrinology and Metabolism 1979 2 197-204. (doi:10.1210/jcem-49-2-197)
19. Clark RW, Schmidt HS & Malarkey WB. Disordered growth hormone and prolactin secretion in primary disorders of sleep. Neurology 1979 6 855-861. (Pubitemid 9160988)
20. The Xyrem® International Study Group. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy. Journal of Clinical Sleep Medicine 2005 1 391-397.
21. Carter LP, Koek W & France CP. Behavioral analyses of GHB: receptor mechanisms. Pharmacology & Therapeutics 2009 1 100-114. (doi:10.1016/j. pharmthera.2008.10.003)
22. Maitre M. The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Progress in Neurobiology 1997 3 337-361. (doi:10.1016/S0301-0082(96)00064-0)
23. Takahara J, Yunoki S, Yakushiji W, Yamauchi J & Yamane Y. Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans. Journal of Clinical Endocrinology and Metabolism 1977 5 1014-1017. (doi:10.1210/jcem-44-5-1014)
24. van Cauter EV, Plat L, Scharf MB, Leproult R, Cespedes S, L'Hermite-Baleriaux M & Copinschi G. Simultaneous stimulation of slow-wave sleep and growth hormone secretion by gammahydroxybutyrate in normal young men. Journal of Clinical Investigation 1997 3 745-753. (doi:10.1172/JCI119587)
25. van Cauter EV, Desir D, Refetoff S, Spire JP, Neol P, L'Hermite M, Robyn C & Copinschi G. The relationship between episodic variations of plasma prolactin and REM-non-REM cyclicity is an artifact. Journal of Clinical Endocrinology and Metabolism 1982 1 70-75. (doi:10.1210/jcem-54-1-70)
26. Obal F Jr, Garcia-Garcia F, Kacsoh B, Taishi P, Bohnet S, Horseman ND & Krueger JM. Rapid eye movement sleep is reduced in prolactin-deficient mice. Journal of Neuroscience 2005 44 10282-10289. (doi:10.1523/JNEUROSCI.2572- 05.2005)
27. Spiegel K, Luthringer R, Follenius M, Schaltenbrand N, Macher JP, Muzet A & Brandenberger G. Temporal relationship between prolactin secretion and slow-wave electroencephalic activity during sleep. Sleep 1995 7 543-548.
28. Parker DC, Rossman LG & Vanderlaan EF. Relation of sleep-entrained human prolactin release to REM-nonREM cycles. Journal of Clinical Endocrinology and Metabolism 1974 4 646-651. (doi:10.1210/jcem-38-4-646)
29. American Sleep Disorders Association. International Classification of Sleep Disorders. Diagnostic and Coding Manual, 2nd edn. Westchester, IL: American Academy of Sleep Medicine, 2005.
30. Iber C, Ancoli-Israel S, Chesson AL & Quan S for the American Academy of Sleep Medicine. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. 1st edn. Westchester IL, 2007.
31. van Cauter EV, Kerkhofs M, Caufriez A, Van OA, Thorner MO & Copinschi G. A quantitative estimation of growth hormone secretion in normal man: reproducibility and relation to sleep and time of day. Journal of Clinical Endocrinology and Metabolism 1992 6 1441-1450. (doi:10.1210/jc.74.6.1441)
32. Liu PY, Keenan DM, Kok P, Padmanabhan V, O'Byrne KT & Veldhuis JD. Sensitivity and specificity of pulse detection using a new deconvolution method. American Journal of Physiology. Endocrinology and Metabolism 2009 2 538-544. (doi:10.1152/ajpendo.00071.2009)
33. Page-Wilson G, Smith PC & Welt CK. Prolactin supresses GnRH but not TSH secretion. Hormone Research 2006 65 31-38. (doi:10.1159/000090377)
34. Brown-Borg HM, Klemcke HG, Borg KE & Klindt J. Prolactin and growth hormone clearance in neonatal boars. Journal of Animal Science 1993 71 2055-2060.
35. Akaike H. A new look at the statistical model identification. IEEE Transactions on Automatic Control 1974 6 716-723. (doi:10.1109/TAC.1974.1100705)
36. Veldhuis JD, Straume M, Iranmanesh A, Mulligan T, Jaffe CA, Barkan A, Johnson ML & Pincus SM. Secretory process regularity monitors neuroendocrine feedback and feedforward signaling strength in humans. American Journal of Physiology 2001 3 R721-R729.
37. Cleveland WS & Devlin S. Locally weighted regression analysis by local fitting. Journal of the American Statistical Association 1988 83 596-640. (doi:10.2307/2289282)
38. Gronfier C & Brandenberger G. Ultradian rhythms in pituitary and adrenal hormones: their relations to sleep. Sleep Medicine Reviews 1998 1 17-29. (doi:10.1016/S1087-0792(98)90051-X)
39. Hsueh YC, Cheng SM & Pan JT. Fasting stimulates tuberoinfundibular dopaminergic neuronal activity and inhibits prolactin secretion in oestrogen-primed ovariectomized rats: involvement of orexin A and neuropeptide Y. Journal of Neuroendocrinology 2002 9 745-752. (doi:10.1046/j.1365-2826.2002. 00835.x)
40. Lopez M, Tena-Sempere M & Dieguez C. Cross-talk between orexins (hypocretins) and the neuroendocrine axes (hypothalamic-pituitary axes). Frontiers in Neuroendocrinology 2010 2 113-127. (doi:10.1016/j.yfrne.2009.07. 001)
41. 2) on immunoreactive and bioactive plasma growth hormone in normal young men. Journal of Clinical Endocrinology and Metabolism 1984 4 705-709. (doi:10.1210/jcem-59-4- 705)